Senti Biosciences, Inc.(SNTI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNTI Senti Biosciences, Inc.

盘后交易 06-01 17:51:30 EDT

0.9803

+0.0287

+3.02%

盘后1.00

+0.0197+2.01%

17:41 EDT

最高1.02	最低0.9400	成交量27.80万
今开0.9426	昨收0.9516	日振幅8.41%
总市值3,053万	流通市值1,429万	总股本3,114万
成交额27.44万	换手率1.91%	流通股本1,458万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNTI","market":"US","secType":"STK","nameCN":"Senti Biosciences, Inc.","latestPrice":0.9803,"timestamp":1780344000000,"preClose":0.9516,"halted":0,"volume":277996,"hourTrading":{"tag":"盘后","latestPrice":1,"preClose":0.9803,"latestTime":"17:41 EDT","volume":660,"amount":648.578304,"timestamp":1780350092729,"change":0.0197,"changeRate":0.020096,"amplitude":0.034683},"delay":0,"changeRate":0.030159730979403054,"floatShares":14577400,"shares":31144500,"eps":-1.9197,"marketStatus":"盘后交易","change":0.0287,"latestTime":"06-01 17:51:30 EDT","open":0.9426,"high":1.02,"low":0.94,"amount":274375.53577376,"amplitude":0.084069,"askPrice":1.04,"askSize":1000,"bidPrice":0.9804,"bidSize":181,"shortable":3,"etf":0,"ttmEps":-1.9197,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780358400000},"marketStatusCode":4,"adr":0,"listingDate":1622001600000,"exchange":"NASDAQ","adjPreClose":0.9516,"preHourTrading":{"tag":"盘前","latestPrice":0.9648,"preClose":0.9516,"latestTime":"09:26 EDT","volume":3018,"amount":2955.9580686,"timestamp":1780320366441,"change":0.0132,"changeRate":0.013871,"amplitude":0.077554},"postHourTrading":{"tag":"盘后","latestPrice":1,"preClose":0.9803,"latestTime":"17:41 EDT","volume":660,"amount":648.578304,"timestamp":1780350092729,"change":0.0197,"changeRate":0.020096,"amplitude":0.034683},"volumeRatio":1.454592},"requestUrl":"/m/hq/s/SNTI/tweets","defaultTab":"tweets","newsList":[{"id":"1137342571","title":"Senti Biosciences公布与FDA就Senti-202注册临床及CMC策略达成积极RMAT会议，并更新关键疗效与持久性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1137342571","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137342571?lang=zh_cn&edition=full","pubTime":"2026-05-14 20:40","pubTimestamp":1778762418,"startTime":"0","endTime":"0","summary":"Senti Biosciences, Inc. 宣布，公司已与美国食品药品监督管理局就Senti-202在复发/难治性急性髓系白血病中的注册临床及化学、制造与控制策略举行了积极的再生医学先进疗法会议。与此同时，公司还公布了Senti-202临床项目中关于疗效与持久性的重要更新信息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNTI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108359760","title":"Senti Biosciences公司签署协议发行最高4000万美元优先担保可转换票据 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1108359760","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108359760?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:10","pubTimestamp":1777666215,"startTime":"0","endTime":"0","summary":"根据最新提交给美国证券交易委员会的文件显示，生物科技企业Senti Biosciences公司已正式达成协议，将发行规模最高达4000万美元的优先担保可转换票据。\n该金融工具具有优先受偿权特性，为投资者提供了债权保障的同时，还赋予其将来将债务转换为公司股权的选择权。此次融资安排体现了市场对这家专注于基因电路技术开发的生物医药企业的信心。\n可转换票据的发行将为企业研发管线推进和运营资金补充提供有力支持。这类融资方式在生物技术领域尤为常见，既能满足企业阶段性资金需求，又为投资者提供了潜在股权增值机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SNTI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184532884","title":"Senti Biosciences, Inc.宣布控股公司重组将于2026年4月16日前生效 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1184532884","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184532884?lang=zh_cn&edition=full","pubTime":"2026-04-02 04:35","pubTimestamp":1775075735,"startTime":"0","endTime":"0","summary":"Senti Biosciences, Inc.已向美国证券交易委员会提交文件，正式宣布一项控股公司重组计划。根据披露，该重组方案预计将于2026年4月16日或之前正式生效。此次公司架构调整标志着Senti Biosciences在战略发展上的重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNTI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614886305","title":"Senti Biosciences, Inc.盘中异动 早盘股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614886305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614886305?lang=zh_cn&edition=full","pubTime":"2026-02-27 00:28","pubTimestamp":1772123324,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日00时28分，Senti Biosciences, Inc.股票出现异动，股价急速拉升5.71%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为2.24%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227002844954224e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227002844954224e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610494802","title":"Senti Biosciences, Inc.盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610494802","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610494802?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:32","pubTimestamp":1770820340,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日22时32分，Senti Biosciences, Inc.股票出现波动，股价急速上涨5.31%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122322097a5d1ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122322097a5d1ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151179337","title":"Senti Biosciences完成针对复发或难治性急性髓系白血病（R/R AML）的Senti-202一期临床试验患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1151179337","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151179337?lang=zh_cn&edition=full","pubTime":"2026-02-11 21:35","pubTimestamp":1770816922,"startTime":"0","endTime":"0","summary":"Senti Biosciences, Inc. 已顺利完成其候选疗法Senti-202针对复发或难治性急性髓系白血病（R/R AML）的一期临床试验患者招募工作。这一关键进展标志着该疗法向临床开发的下一个阶段迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605875482","title":"Senti Biosciences, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605875482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605875482?lang=zh_cn&edition=full","pubTime":"2026-01-24 00:16","pubTimestamp":1769185019,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日00时16分，Senti Biosciences, Inc.股票出现波动，股价大幅下挫5.15%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124001659a44f1a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124001659a44f1a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590347834","title":"美股异动 | 1期SENTI-202试验数据积极 Senti Biosciences(SNTI.US)开盘涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590347834","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590347834?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:45","pubTimestamp":1765291511,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，Senti Biosciences(SNTI.US)开盘涨超7%，报2.54美元。消息面上，Senti Bio报告了更新的1期SENTI-202在R/R AML中的数据，显示50%的总缓解率(ORR)、42%的完全缓解/部分血液学缓解(CR/CRh)，且大多数为微小残留病阴性(MRD-Negative)持久应答，并获得RMAT支持以推进至关键研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美股异动 | 1期SENTI-202试验数据积极 Senti Biosciences(SNTI.US)开盘涨超7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105566673","title":"Senti Bio获得FDA再生医学先进疗法(RMAT)认证，Senti-202用于治疗成人复发性或难治性急性髓系白血病","url":"https://stock-news.laohu8.com/highlight/detail?id=1105566673","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105566673?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:02","pubTimestamp":1765281749,"startTime":"0","endTime":"0","summary":"Senti Bio获得FDA再生医学先进疗法(RMAT)认证，Senti-202用于治疗成人复发性或难治性急性髓系白血病","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588041089","title":"Senti Biosciences, Inc.盘中异动 股价大涨5.34%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588041089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588041089?lang=zh_cn&edition=full","pubTime":"2025-12-03 04:35","pubTimestamp":1764707752,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日04时35分，Senti Biosciences, Inc.股票出现波动，股价急速拉升5.34%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家处于临床阶段的生物技术公司，致力于开发下一代细胞和基因疗法，这些疗法利用其基因回路平台技术为患有不治之症的患者提供治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203043552a4c8b600&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203043552a4c8b600&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518717227","title":"Senti Biosciences, Inc.股价重挫10.51% 市值跌159.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518717227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518717227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613722,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Senti Biosciences, Inc.股票出现异动，股价快速下跌10.51%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2175.89%、425.85%、66.65%，振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进，振幅分别为100.05%、98.72%、98.49%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213522abf2fdc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213522abf2fdc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517161945","title":"Senti Biosciences, Inc.盘中异动 早盘股价大涨8.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161945?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186165,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分，Senti Biosciences, Inc.股票出现波动，股价大幅拉升8.68%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。其相关个股中，Chimerix, Inc.、Silexion Therapeutics Corp、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为595.83%、267.83%、215.60%，振幅较大的相关个股有Nkgen Biotech, Inc.、Silexion Therapeutics Corp、Aditxt, Inc.，振幅分别为40.77%、33.33%、23.90%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224925989d49f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224925989d49f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516652680","title":"Senti Biosciences, Inc.盘中异动 股价大跌6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652680","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516652680?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:33","pubTimestamp":1741026790,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时33分，Senti Biosciences, Inc.股票出现波动，股价急速下挫6.98%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4396.71%、193.31%、179.43%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023310a25d84fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023310a25d84fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","SNTI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514837892","title":"Senti Biosciences, Inc.盘中异动 股价大跌5.46%报3.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514837892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514837892?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:39","pubTimestamp":1740753580,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时39分，Senti Biosciences, Inc.股票出现波动，股价大幅下挫5.46%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223940abe0ecfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223940abe0ecfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514384007","title":"Senti Biosciences, Inc.盘中异动 早盘快速下挫5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514384007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514384007?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:03","pubTimestamp":1740672239,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时03分，Senti Biosciences, Inc.股票出现波动，股价大幅跳水5.99%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280004009632c4d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280004009632c4d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514019392","title":"Senti Biosciences, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514019392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514019392?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:00","pubTimestamp":1740499202,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时00分，Senti Biosciences, Inc.股票出现波动，股价快速下跌5.21%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1203.46%、1099.45%、758.15%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc，振幅分别为224.93%、87.83%、64.05%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600000298925fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600000298925fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNTI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514775864","title":"Senti Biosciences, Inc.盘中异动 早盘急速下挫7.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775864?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:52","pubTimestamp":1740412328,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时52分，Senti Biosciences, Inc.股票出现波动，股价急速跳水7.07%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235208962eab7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224235208962eab7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512482725","title":"Senti Biosciences, Inc.盘中异动 急速跳水5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512482725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512482725?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:08","pubTimestamp":1739984882,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时08分，Senti Biosciences, Inc.股票出现波动，股价大幅跳水5.20%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200108039628e68d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200108039628e68d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNTI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512819263","title":"Senti Biosciences, Inc.盘中异动 股价大跌5.28%报4.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512819263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512819263?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:59","pubTimestamp":1739912396,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时59分，Senti Biosciences, Inc.股票出现波动，股价大幅跳水5.28%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为980.58%、229.22%、176.84%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219045956988a3999&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219045956988a3999&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511897694","title":"Senti Biosciences, Inc.盘中异动 急速拉升5.72%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511897694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511897694?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:25","pubTimestamp":1739546751,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时25分，Senti Biosciences, Inc.股票出现波动，股价大幅拉升5.72%。Senti Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Senti Biosciences, Inc.公司简介：Senti Biosciences Inc 是一家临床阶段生物技术公司，利用其基因电路平台技术开发下一代细胞和基因疗法，以对抗挑战性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232551abcf1313&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232551abcf1313&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SNTI","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sentibio.com","stockEarnings":[{"period":"1week","weight":-0.0358},{"period":"1month","weight":-0.0327},{"period":"3month","weight":0.0082},{"period":"6month","weight":-0.5733},{"period":"1year","weight":-0.694},{"period":"ytd","weight":-0.085}],"compareEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.0631},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.107},{"period":"1year","weight":0.2821},{"period":"ytd","weight":0.1093}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Senti Biosciences Holdings, Inc.于2021年3月1日在特拉华州成立。该公司是一家临床阶段的生物技术公司，利用其基因电路平台技术为患有不治之症的患者开发下一代细胞和基因疗法。该公司的使命是创造新一代更智能的药物，使用新颖和前所未有的方法战胜复杂的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.037903},{"month":2,"riseRate":0.2,"avgChangeRate":-0.117173},{"month":3,"riseRate":0.2,"avgChangeRate":-0.07377},{"month":4,"riseRate":0.4,"avgChangeRate":-0.016933},{"month":5,"riseRate":0.4,"avgChangeRate":-0.057207},{"month":6,"riseRate":0,"avgChangeRate":-0.301397},{"month":7,"riseRate":0.4,"avgChangeRate":0.120052},{"month":8,"riseRate":0.4,"avgChangeRate":-0.119944},{"month":9,"riseRate":0.4,"avgChangeRate":-0.088688},{"month":10,"riseRate":0.6,"avgChangeRate":0.032318},{"month":11,"riseRate":0.4,"avgChangeRate":0.12033},{"month":12,"riseRate":0.4,"avgChangeRate":0.047383}],"exchange":"NASDAQ","name":"Senti Biosciences, Inc.","nameEN":"Senti Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Senti Biosciences, Inc.(SNTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Senti Biosciences, Inc.(SNTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Senti Biosciences, Inc.,SNTI,Senti Biosciences, Inc.股票,Senti Biosciences, Inc.股票老虎,Senti Biosciences, Inc.股票老虎国际,Senti Biosciences, Inc.行情,Senti Biosciences, Inc.股票行情,Senti Biosciences, Inc.股价,Senti Biosciences, Inc.股市,Senti Biosciences, Inc.股票价格,Senti Biosciences, Inc.股票交易,Senti Biosciences, Inc.股票购买,Senti Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Senti Biosciences, Inc.(SNTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Senti Biosciences, Inc.(SNTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}